La protonterapia debuta en España de la mano del mejor talento médico internacional
La protonterapia española de Quirónsalud Madrid en las manos del mejor talento médico internacional, el único centro de estas características en España.
Related Articles
Outcomes of Allogeneic HCT in Hodgkin Lymphoma in the Era of Checkpoint Inhibitors: A Joint CIBMTR and EBMT Analysis.
Key Points. Prior exposure to CPI is associated with increased PFS due to decreased incidence of relapse after HCT, suggesting an increased GVL.PTCy based
Autologous stem cell transplantation for relapsed/refractory large B-cell lymphoma: a multicenter GETH-TC/GELTAMO study
Key PointsOur results indicate that ASCT is a curative option for patients with chemosensitive disease especially in CR after salvage.ASCT could still be c
Bridging radiotherapy before chimeric antigen receptor T cells for B-cell lymphomas: an ILROG multicenter study
Key PointsBr-RT before CAR-T was well tolerated with minimal toxicity in this large multicenter study.Comprehensive Br-RT and LDH normalization after RT bu
Immunological consequences of CAR T-cell therapy: an analysis of infectious complications and immune reconstitution
Key PointsCAR T cells induce a cellular and humoral immunodeficiency resulting in an initial susceptibility for bacterial and later viral infections.Severe
Calibrating Chimeric Antigen Receptor (CAR) Signaling to Improve CAR T-Cell Therapies
View all available purchase options and get full access to this article. The following represents disclosure information provided by authors of this manuscript. All relationships…
Anti‐CD19 CAR T‐cell therapy for patients with Richter transformation: A LYSA study from the DESCAR‐T registry
Click on the article title to read more.
Long-Term Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma: An Italian Multicenter Collaborative Study
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) was long considered the last hope for lymphoma patients with recurrence after heavy pre-treatments and/or refractory disease. Despite its…
Effect of Sacubitril/Valsartan or Enalapril on Left Ventricular Function in Patients With Hematologic Malignancies Treated With Bone Marrow Transplantation: A Randomized Controlled Trial
AbstractBackgroundIn patients with bone marrow transplantation (BMT) for hematologic malignancies, evidence for prevention of cancer therapy-related cardiac dysfunction (CTRCD) remains limited.Obje…
Membership and Communities – ESC Council of Cardio-Oncology
Your access to the latest cardiovascular news, science, tools and resources.
Permissive Cardiotoxicity: The Clinical Crucible of Cardio-Oncology
The field of cardio-oncology was born from the necessity for recognition and management of cardiovascular diseases among patients with cancer. This need for this specialty…